Beijing Epoch-Angel Bio-Technology Co., Ltd. Completed its Series A Equity Financing.
Han Kun represented OrbiMed Advisors in its Series A investment in Epoch-Angel Bio-Technology Co., Ltd., a company engaged in the R&D, manufacture and sale of invisible aligners.
Han Kun primarily assisted in the design of financing structures and preparation of various financing documents and participated in the negotiation process. This deal closed recently.